- Home
- ELEV vs XCUR Comparison
ELEV vs XCUR Comparison
Compare ELEV & XCUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELEV
- XCUR
- Stock Information
- Founded
- ELEV 2019
- XCUR 2011
- Country
- ELEV United States
- XCUR United States
- Employees
- ELEV N/A
- XCUR N/A
- Industry
- ELEV Biotechnology: Pharmaceutical Preparations
- XCUR Biotechnology: Pharmaceutical Preparations
- Sector
- ELEV Health Care
- XCUR Health Care
- Exchange
- ELEV Nasdaq
- XCUR Nasdaq
- Market Cap
- ELEV 37.6M
- XCUR 43.6M
- IPO Year
- ELEV 2021
- XCUR N/A
- Fundamental
- Price
- ELEV $0.66
- XCUR $13.66
- Analyst Decision
- ELEV Buy
- XCUR
- Analyst Count
- ELEV 6
- XCUR 0
- Target Price
- ELEV $7.20
- XCUR N/A
- AVG Volume (30 Days)
- ELEV 4.3M
- XCUR 146.5K
- Earning Date
- ELEV 03-05-2025
- XCUR 11-14-2024
- Dividend Yield
- ELEV N/A
- XCUR N/A
- EPS Growth
- ELEV N/A
- XCUR N/A
- EPS
- ELEV N/A
- XCUR N/A
- Revenue
- ELEV N/A
- XCUR $500,000.00
- Revenue This Year
- ELEV N/A
- XCUR N/A
- Revenue Next Year
- ELEV N/A
- XCUR N/A
- P/E Ratio
- ELEV N/A
- XCUR N/A
- Revenue Growth
- ELEV N/A
- XCUR N/A
- 52 Week Low
- ELEV $0.50
- XCUR $1.44
- 52 Week High
- ELEV $5.83
- XCUR $36.00
- Technical
- Relative Strength Index (RSI)
- ELEV 48.99
- XCUR 52.19
- Support Level
- ELEV $0.65
- XCUR $8.51
- Resistance Level
- ELEV $0.98
- XCUR $12.65
- Average True Range (ATR)
- ELEV 0.12
- XCUR 1.95
- MACD
- ELEV -0.01
- XCUR 0.12
- Stochastic Oscillator
- ELEV 18.38
- XCUR 78.01
About ELEV Elevation Oncology Inc. Common stock
Elevation Oncology Inc is an oncology company focused on the development of targeted therapeutics for the treatment of cancer in genomically defined patient populations. Its lead program is focused on neuregulin-1, or NRG1, fusions, which are rare genomic alterations that have the potential to be therapeutically actionable through targeted HER3 inhibition.
About XCUR Exicure Inc.
Exicure Inc is a biotechnology company that develops nucleic acid therapies targeting ribonucleic acid against validated targets for neurological disorders and hair loss. It operates in a single segment, which is the discovery, research, and development of treatments based on its SNA (Spherical Nucleic Acid) technology.